These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21029347)

  • 1. Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study.
    Adel A; Abdel-Salam Z; Nammas W
    J Clin Hypertens (Greenwich); 2010 Oct; 12(10):820-5. PubMed ID: 21029347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK; Watts GF; Chan DC; Stanton K
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study.
    Dalla Nora E; Passaro A; Zamboni PF; Calzoni F; Fellin R; Solini A
    J Endocrinol Invest; 2003 Jan; 26(1):73-8. PubMed ID: 12602538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.
    Usharani P; Mateen AA; Naidu MU; Raju YS; Chandra N
    Drugs R D; 2008; 9(4):243-50. PubMed ID: 18588355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium)].
    Gómez-Doblas JJ; Jiménez-Navarro MF; García-Pinilla JM; Rodríguez-Bailón I; Robledo J; Cabrera F; Espinosa S; de Teresa E
    Med Clin (Barc); 2006 Mar; 126(9):325-8. PubMed ID: 16650363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.
    Ozkiris A; Erkiliç K; Koç A; Mistik S
    Br J Ophthalmol; 2007 Jan; 91(1):69-73. PubMed ID: 16973667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.
    Economides PA; Caselli A; Tiani E; Khaodhiar L; Horton ES; Veves A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):740-7. PubMed ID: 14764790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
    Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a single 20-mg tablet of Atorvastatin on brachial artery blood flow in normolipidemic male smokers versus nonsmokers.
    Iida K; Goland S; Akima T; Luo H; Birnbaum Y; Siegel RJ
    Am J Cardiol; 2007 Sep; 100(5):881-4. PubMed ID: 17719338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.
    van Venrooij FV; van de Ree MA; Bots ML; Stolk RP; Huisman MV; Banga JD;
    Diabetes Care; 2002 Jul; 25(7):1211-6. PubMed ID: 12087021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy.
    Philpott AC; Hubacek J; Sun YC; Hillard D; Anderson TJ
    Atherosclerosis; 2013 Feb; 226(2):453-8. PubMed ID: 23174368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
    van Hoek M; van Tol A; van Vark-van der Zee LC; Jansen H; Kastelein JJ; Sijbrands EJ; Dallinga-Thie GM
    Curr Med Res Opin; 2009 Jan; 25(1):93-101. PubMed ID: 19210142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl.
    Wassmann S; Ribaudo N; Faul A; Laufs U; Böhm M; Nickenig G
    Am J Cardiol; 2004 Jan; 93(1):84-8. PubMed ID: 14697473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.
    Ferreira GA; Navarro TP; Telles RW; Andrade LE; Sato EI
    Rheumatology (Oxford); 2007 Oct; 46(10):1560-5. PubMed ID: 17693444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI).
    Jani RH; Pai V; Jha P; Jariwala G; Mukhopadhyay S; Bhansali A; Joshi S
    Diabetes Technol Ther; 2014 Feb; 16(2):63-71. PubMed ID: 24138536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.